HomeTYRA • NASDAQ
add
Tyra Biosciences Inc
Previous close
$36.22
Day range
$36.27 - $37.84
Year range
$6.42 - $37.84
Market cap
1.99B USD
Avg Volume
1.10M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 36.52M | 22.77% |
Net income | -33.83M | -32.31% |
Net profit margin | — | — |
Earnings per share | -0.57 | -32.56% |
EBITDA | -36.38M | -22.92% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 256.00M | -25.02% |
Total assets | 282.61M | -22.27% |
Total liabilities | 23.43M | 14.82% |
Total equity | 259.18M | — |
Shares outstanding | 53.87M | — |
Price to book | 7.50 | — |
Return on assets | -31.24% | — |
Return on capital | -33.11% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -33.83M | -32.31% |
Cash from operations | -23.62M | -20.59% |
Cash from investing | 34.38M | 394.06% |
Cash from financing | 4.68M | 563.31% |
Net change in cash | 15.44M | 229.43% |
Free cash flow | -16.08M | -59.43% |
About
Founded
2018
Headquarters
Website
Employees
87
